Cited by 692Advanced Glycation End Products researchImmune Response and InflammationSystemic Lupus Erythematosus Research

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

Harris, Helena Erlandsson, Andersson, Ulf, Pisetsky, David S.·2012·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.222

Open this paper in CoChat — free account

Abstract

HMGB1 is a non-histone nuclear protein that can serve as an alarmin to drive the pathogenesis of inflammatory and autoimmune disease. Although primarily located in the cell nucleus, HMGB1 can translocate to the cytoplasm, as well as the extracellular space, during cell activation and cell death; during activation, HMGB1 can undergo post-translational modifications. The activity of HMGB1 varies with the redox states of the cysteine residues, which are required for binding to TLR4. In addition to stimulating cells directly, HMGB1 can form immunostimulatory complexes with cytokines and other endogenous and exogenous factors. In the synovia of patients with rheumatoid arthritis, as well as animal models of this disease, extranuclear expression of HMGB1 is increased and blockade of HMGB1 expression attenuates disease in animal models. In systemic lupus erythematosus, HMGB1 can be a component of immune complexes containing anti-DNA because of its interaction with DNA. In myositis, expression of HMGB1 is enhanced in inflamed muscle and can perturb muscle function. Together, these findings indicate that HMGB1 might be an important mediator and biomarker in rheumatic diseases as well as a target of new therapy.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.222

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 retracted

Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1)
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
Self-citation
Retracted
Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity
Antoine, D. J., Williams, D. P., Kipar, A., Laverty, H., & Park, B. K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00126 · Cited by 102
Retracted
Increased serum high mobility group box-1 level in Churg–Strauss syndrome THIS ARTICLE HAS BEEN RETRACTED
Taira, T., Matsuyama, W., Mitsuyama, H., Kawahara, K.-I., Higashimoto, I., Maruyama, I., Osame, M., & Arimura, K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03347.x · Cited by 20
Retracted
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citation
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Self-citation
High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citation
Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Caspase‐1‐induced pyroptotic cell death
Miao, E. A., Rajan, J. V., & Aderem, A. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01044.x · Cited by 1,162
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Self-citation
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23025 · Cited by 866
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lü, B., Chavan, S. S., Rosas‐Ballina, M., Al‐Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 812
Self-citation
CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786
Mechanisms of regulated unconventional protein secretion
Nickel, W., & Rabouille, C. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2617 · Cited by 726
HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura, T., Negishi, H., Nakasato, M., Lu, Y., Hangai, S., Koshiba, R., et al. (2009) · Nature · doi:10.1038/nature08512 · Cited by 708
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Iyer, S. S., Pulskens, W. P., Sadler, J. J., Butter, L. M., Teske, G. J., Ulland, T. K., Eisenbarth, S. C., Florquin, S., Flavell, R. A., Leemans, J. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908698106 · Cited by 691
Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
Kazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.013 · Cited by 627
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Rovere, P. Q., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Müller, S., Iannacone, M., Traversari, C., et al. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400205 · Cited by 591
The extracellular release of HMGB1 during apoptotic cell death
Bell, C. W., Jiang, W., Reich, C. F., & Pisetsky, D. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00616.2005 · Cited by 538
Self-citation
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice
Calogero, S., Grassi, F., Aguzzi, A., Voigtländer, T., Ferrier, P., Ferrari, S., & Bianchi, M. E. (1999) · Nature Genetics · doi:10.1038/10338 · Cited by 528
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
Urbonaviciute, V., Fürnrohr, B. G., Meister, S., Munoz, L. E., Heyder, P., Marchis, F. D., Bianchi, M. E., Kirschning, C. J., Wagner, H., Manfredi, A. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081165 · Cited by 517
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S. S., Dragoi, A., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 482
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
Taniguchi, N., Kawahara, K.-I., Yone, K., Hashiguchi, T., Yamakuchi, M., Goto, M., Inoue, K., Yamada, S., Ijiri, K., Matsunaga, S., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10859 · Cited by 482
Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia
Lamkanfi, M., Sarkar, A., Walle, L. V., Vitari, A. C., Amer, A. O., Wewers, M. D., Tracey, K. J., Kanneganti, T., & Dixit, V. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000803 · Cited by 482
HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
Sha, Y., Zmijewski, J. W., Xu, Z., & Abraham, E. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2531 · Cited by 395
Rage and arthritis: The G82S polymorphism amplifies the inflammatory response
Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., et al. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363861 · Cited by 383
The type I interferon system in systemic lupus erythematosus
Rönnblom, L., Eloranta, M., & Alm, G. V. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21571 · Cited by 340
Successful treatment of collagen‐induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity
Kokkola, R., Li, J., Sundberg, E., Aveberger, A.-C., Palmblad, K., Yang, H., Tracey, K. J., Andersson, J., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Self-citation
High mobility group protein-1 (HMG-1) is a unique activator of p53Preprint
Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. L. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 320
Anti-Double-Stranded DNA Antibodies and Immunostimulatory Plasmid DNA in Combination Mimic the Endogenous IFN-α Inducer in Systemic Lupus Erythematosus
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 300
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
Kokkola, R., Sundberg, E., Ulfgren, A. ‐., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X. ‐., Furie, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10540 · Cited by 290
Self-citation
The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
Hreggvidsdottir, H. S., Östberg, T., Wähämaa, H., Schierbeck, H., Aveberger, A.-C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., & Harris, H. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908548 · Cited by 289
Self-citation
Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation
Palumbo, R., Gálvez, B. G., Pusterla, T., Marchis, F. D., Cossu, G., Marcu, K. B., & Bianchi, M. E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704015 · Cited by 250
Post-translational Methylation of High Mobility Group Box 1 (HMGB1) Causes Its Cytoplasmic Localization in Neutrophils
Ito, I., Fukazawa, J., & Yoshida, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608467200 · Cited by 243
High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity
Evankovich, J. W., Cho, S. W., Zhang, R., Cardinal, J. S., Dhupar, R., Zhang, L., Klune, J. R., Zlotnicki, J. P., Billiar, T. R., & Tsung, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128348 · Cited by 242
Innate and adaptive immune responses to cell death
Rock, K. L., Lai, J., & Kono, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01040.x · Cited by 226
High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo
Antoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp235 · Cited by 223
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
Pullerits, R., Jonsson, I., Verdrengh, M., Bokarewa, M. I., Andersson, U., Erlandsson-Harris, H., & Tarkowski, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11028 · Cited by 191
Self-citation
Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis
Goldstein, R. S., Bruchfeld, A. N., Yang, L., Qureshi, A. R., Gallowitsch‐Puerta, M., Patel, N. B., Huston, B. J., Chavan, S. S., Rosas‐Ballina, M., Gregersen, P. K., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00108.goldstein · Cited by 189
HMGB1 Is Phosphorylated by Classical Protein Kinase C and Is Secreted by a Calcium-Dependent Mechanism
Oh, Y. J., Youn, J. H., Ji, Y., Lee, S. E., Lim, K. J., Choi, J. E., & Shin, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801873 · Cited by 180
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Abdulahad, D. A., Westra, J., Bijzet, J., Limburg, P. C., Kallenberg, C. G. M., & Bijl, M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3332 · Cited by 170
Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic mice
Tsoyi, K., Jang, H. J., Nizamutdinova, I. T., Kim, Y. M., Lee, Y. S., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01126.x · Cited by 158
Factors masking HMGB1 in human serum and plasma
Urbonaviciute, V., Fürnrohr, B. G., Weber, C., Haslbeck, M., Wilhelm, S., i, M. H., & Voll, R. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306196 · Cited by 157
HMGB proteins and transcriptional regulation
Ueda, T., & Yoshida, M. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.005 · Cited by 154
Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus
Popovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H. E., Wahren‐Herlenius, M., & Nyberg, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21398 · Cited by 140
Self-citation
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis
de Wouwer, M. V., Plaisance, S., Vriese, A. D., Waelkens, E., Collen, D., Persson, J., Daha, M. R., & Conway, E. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02033.x · Cited by 140
High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
Wähämaa, H., Schierbeck, H., Hreggvidsdottir, H. S., Palmblad, K., Aveberger, A.-C., Andersson, U., & Harris, H. E. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3450 · Cited by 138
Self-citation
Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis
Hamada, T., Torikai, M., Kuwazuru, A., Tanaka, M., Horai, N., Fukuda, T., Yamada, S., Nagayama, S., Hashiguchi, K., Sunahara, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23729 · Cited by 130
Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models
Schierbeck, H., Lundbäck, P., Palmblad, K., Klevenvall, L., Erlandsson-Harris, H., Andersson, U., & Ottosson, L. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00264 · Cited by 122
Self-citation
Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus
Ma, C., Jiao, Y., Zhang, J., Yang, Q., Zhang, Z., Shen, Y., Chen, Z., & Zhao, Y. (2010) · Rheumatology International · doi:10.1007/s00296-010-1636-6 · Cited by 115
Down‐regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids
Ulfgren, A., Grundtman, C., Borg, K., Alexanderson, H., Andersson, U., Harris, H. E., & Lundberg, I. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20220 · Cited by 112
Self-citation
High Mobility Group Box Protein 1 (HMGB1)-Partner Molecule Complexes Enhance Cytokine Production by Signaling Through the Partner Molecule Receptor
Hreggvidsdottir, H. S., Lundberg, A. M., Aveberger, A.-C., Klevenvall, L., Andersson, U., & Harris, H. E. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00327 · Cited by 108
Self-citation
High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
García-Arnandis, I., Guillén, M. I., Sancho, F. G., Pelletier, J., Martel‐Pelletier, J., & Alcaraz, M. J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3124 · Cited by 106
Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration
Mori, R. D., Straino, S., Carlo, A. D., Mangoni, A., Pompilio, G., Palumbo, R., Bianchi, M. E., Capogrossi, M. C., & Germani, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153429 · Cited by 100
Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels
af Klint, E., Grundtman, C., Engström, M., Catrina, A. I., Makrygiannakis, D., Klareskog, L., Andersson, U., & Ulfgren, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21488 · Cited by 98
Self-citation
HMGB1 interacts differentially with members of the Rel family of transcription factors
Agresti, A., Lupo, R., Bianchi, M. E., & Müller, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00184-0 · Cited by 95
Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus
Barkauskaite, V., Ek, M., Popović, K. J., Harris, H. E., Wahren‐Herlenius, M., & Nyberg, F. (2007) · Lupus · doi:10.1177/0961203307081895 · Cited by 88
Self-citation
Identification of lipopolysaccharide‐binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model
Youn, J. H., Kwak, M. S., Wu, J., Kim, E. S., Ji, Y., Min, H. J., Yoo, J., Choi, J. E., Cho, H., & Shin, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201141391 · Cited by 86
Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors
Verrijdt, G., Haelens, A., Schoenmakers, E., Rombauts, W., & Claessens, F. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610097 · Cited by 83
Developments in the scientific understanding of lupus
Ardoin, S. P., & Pisetsky, D. S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2488 · Cited by 83
Self-citation
Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome
Ek, M., Popovic, K., Harris, H. E., Söderberg‐Nauclér, C., & Wahren‐Herlenius, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21969 · Cited by 82
Self-citation
Cyclophilin A release as a biomarker of necrotic cell death
Christofferson, D. E., & Yuan, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.123 · Cited by 80
Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus
LI, J., Xie, H., WEN, T., Liu, H., Zhu, W., & Chen, X. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090663 · Cited by 78
Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies
Grundtman, C., Bruton, J. D., Yamada, T., Östberg, T., Pisetsky, D. S., Harris, H. E., Andersson, U., Lundberg, I. E., & Westerblad, H. (2009) · The FASEB Journal · doi:10.1096/fj.09-144782 · Cited by 78
Self-citation
High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle
Vezzoli, M., Castellani, P., Corna, G., Castiglioni, A., Bosurgi, L., Monno, A., Brunelli, S., Manfredi, A. A., Rubartelli, A., & Rovere, P. Q. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3341 · Cited by 76
New high mobility group box 1 assay system
Yamada, S., Yakabe, K., Ishii, J., Imaizumi, H., & Maruyama, I. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.04.016 · Cited by 76
Autoantibodies to nonhistone chromosomal proteins HMG‐1 and HMG‐2 in sera of patients with juvenile rheumatoid arthritis
Wittemann, B., Neuer, G., Michels, H., Truckenbrodt, H., & Bautz, F. A. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330910 · Cited by 75
Cyclophilin A Is a Damage-Associated Molecular Pattern Molecule That Mediates Acetaminophen-Induced Liver Injury
Dear, J. W., Simpson, K. J., Nicolai, M. P. J., Catterson, J. H., Street, J. M., Huizinga, T., Craig, D. G. N., Dhaliwal, K., Webb, S., Bateman, D. N., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100165 · Cited by 73
Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors
Verrijdt, G., Haelens, A., Schoenmakers, E., Rombauts, W., & Claessens, F. (2001) · Biochemical Journal · doi:10.1042/bj3610097 · Cited by 64
Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus
Jiang, W., & Pisetsky, D. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074484 · Cited by 62
Self-citation
Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs)
Yanai, H., Chiba, S., Ban, T., Nakaima, Y., Onoe, T., Honda, K., Ohdan, H., & Taniguchi, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108535108 · Cited by 62
High-Mobility Group Box-1 Protein (HMGB1) Is Increased in Antineutrophilic Cytoplasmatic Antibody (ANCA)-Associated Vasculitis with Renal Manifestations
Bruchfeld, A. N., Wendt, M., Bratt, J., Qureshi, A. R., Chavan, S. S., Tracey, K. J., Palmblad, K., & Gunnarsson, I. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00132 · Cited by 61
Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model
Östberg, T., Kawane, K., Nagata, S., Yang, H., Chavan, S. S., Klevenvall, L., Bianchi, M. E., Harris, H. E., Andersson, U., & Palmblad, K. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27590 · Cited by 58
Self-citation
Contribution of Cyclophilin A to the Regulation of Inflammatory Processes in Rheumatoid Arthritis
Wang, L., Wang, C., Jia, J., Ma, X., Li, Y., Zhu, H., Tang, H., Chen, Z., & Zhu, P. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9329-1 · Cited by 57
Pivotal Advance: Inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate
Zetterström, C. K., Jiang, W., Wähämaa, H., Östberg, T., Aveberger, A.-C., Schierbeck, H., Lotze, M. T., Andersson, U., Pisetsky, D. S., & Harris, H. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507323 · Cited by 54
Self-citation
Determinants of HMGB Proteins Required To Promote RAG1/2-Recombination Signal Sequence Complex Assembly and Catalysis during V(D)J Recombination
Dai, Y., Wong, B., Yen, Y., Oettinger, M. A., Kwon, J., & Johnson, R. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4413-4425.2005 · Cited by 49
Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis
Wibisono, D., Csernok, E., Lamprecht, P., Holle, J. U., Gross, W. L., & Moosig, F. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119172 · Cited by 49
Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis
Palmblad, K., Sundberg, E., Diez, M., Söderling, R., Aveberger, A.-C., Andersson, U., & Harris, H. E. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2155 · Cited by 48
Self-citation
High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease
Hoshina, T., Kusuhara, K., Ikeda, K., Mizuno, Y., Saito, M., & Hara, T. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740802144143 · Cited by 45
Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity
Hayashi, A., Nagafuchi, H., Ito, I., Hirota, K., Yoshida, M., & Ozaki, S. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0151-7 · Cited by 45
Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner
Naghavi, M. H., Nowak, P., Andersson, J., Sönnerborg, A. B., Yang, H., Tracey, K. J., & Vahlne, A. G. (2003) · Virology · doi:10.1016/s0042-6822(03)00453-7 · Cited by 39
Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's)
Henes, F. O., Chen, Y., Bley, T. A., Fabel, M., Both, M., Herrmann, K., Csernok, E., Gross, W. L., & Moosig, F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146456 · Cited by 39
Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity
Hayashi, A., Nagafuchi, H., Ito, I., et al. (2009) · Modern Rheumatology · doi:10.3109/s10165-009-0151-7 · Cited by 34
A High-Sensitivity Method for Detection and Measurement of HMGB1 Protein Concentration by High-Affinity Binding to DNA Hemicatenanes
Gaillard, C., Borde, C., Gozlan, J., Maréchal, V., & Strauss, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002855 · Cited by 33
Serum Levels of HMGB1 in Postmenopausal Patients with Rheumatoid Arthritis: Associations with Proinflammatory Cytokines, Acute-phase Reactants, and Clinical Disease Characteristics
Pullerits, R., Urbonaviciute, V., Voll, R. E., Forsblad‐d’Elia, H., & Carlsten, H. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110091 · Cited by 27
PCA-ELISA: A sensitive method to quantify free and masked forms of HMGB1
Barnay‐Verdier, S., Gaillard, C., Messmer, M., Borde, C., Gibot, S., & Maréchal, V. (2011) · Cytokine · doi:10.1016/j.cyto.2011.03.011 · Cited by 24
An Elevated Value of High Mobility Group Box 1 is a Potential Marker for Poor Response to High-Dose of Intravenous Immunoglobulin Treatment in Patients With Kawasaki Syndrome
Eguchi, T., Nomura, Y., Hashiguchi, T., Masuda, K., Arata, M., Hazeki, D., Ueno, K., Nishi, J., Kawano, Y., & Maruyama, I. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818ffe60 · Cited by 23
Extracellular High-Mobility Group Box 1 is Increased in Patients with Behçet's Disease with Intestinal Involvement
Ahn, J. K., Cha, H., Bae, E.-K., Lee, J., & Koh, E. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.5.697 · Cited by 23
HMGB1-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor
Hreggvidsdottir, H. S., Lundberg, A. M., Aveberger, A.-C., Klevenvall, L., Andersson, U., & Harris, H. E. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201238.19 · Cited by 6
Self-citation

Flagged first, then by citations

Sorted by citations

Macrophage Polarization in Inflammatory Diseases
Liu, Y., Zou, X., Chai, Y., & Yao, Y.-M. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8879 · Cited by 1,135
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
HMGB1 in health and disease
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
The role of oxidative stress during inflammatory processes
Lugrin, J., Rosenblatt‐Velin, N., Parapanov, R., & Liaudet, L. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 766
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Delgado‐Rizo, V., Martinez-Guzman, M. A., Íñiguez-Gutiérrez, L., García-Orozco, A., Alvarado‐Navarro, A., & Fafutis‐Morris, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00081 · Cited by 703

See all 692

Authors: Harris, H. E., Andersson, U., & Pisetsky, D. S.
Affiliations: Karolinska Institutet (SE)
Karolinska University Hospital (SE)
Durham VA Medical Center (US)
Corresponding author: Pisetsky, David S.
ORCID: Harris, Helena Erlandsson
Pisetsky, David S.
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2012-01-31
Volume: 8
Issue: 4
Pages: 195-202
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.222
OpenAlex: W1972204333
Cited by: 689
References: 93
Citations by year: 2026: 20 · 2025: 31 · 2024: 32 · 2023: 34 · 2022: 54 · 2021: 61 · 2020: 50 · 2019: 59 · 2018: 65 · 2017: 57 · 2016: 53 · 2015: 52 · 2014: 55 · 2013: 49 · 2012: 16
FWCI: 6.55
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Funders: Vetenskapsrådet
Reumatikerförbundet
National Institutes of Health
National Institute of Allergy and Infectious Diseases (AI-056363, U19AI056363)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords: HMGB1, alarmins, non-histone nuclear proteins, rheumatoid arthritis, systemic lupus erythematosus, myositis, inflammation, autoimmune disease, TLR4, post-translational modification, cysteine redox state, extracellular HMGB1, immune complexes, anti-DNA antibodies, synovium, biomarkers, therapeutic target
MeSH terms: Animals, Autoimmune Diseases, DNA-Binding Proteins, Humans, Inflammation, Rheumatic Diseases, Signal Transduction, HMGB1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks